Literature DB >> 15709159

Plasma protein profiling by mass spectrometry for cancer diagnosis: opportunities and limitations.

Eleftherios P Diamandis, Da-Elene van der Merwe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15709159

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  20 in total

Review 1.  Protein biomarkers of ovarian cancer: the forest and the trees.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Future Oncol       Date:  2012-01       Impact factor: 3.404

Review 2.  Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review.

Authors:  Manfred Dietel; Christine Sers
Journal:  Virchows Arch       Date:  2006-04-22       Impact factor: 4.064

Review 3.  Penalized feature selection and classification in bioinformatics.

Authors:  Shuangge Ma; Jian Huang
Journal:  Brief Bioinform       Date:  2008-06-18       Impact factor: 11.622

4.  Proteomic analyses of human plasma: Venus versus Mars.

Authors:  Christopher C Silliman; Monika Dzieciatkowska; Ernest E Moore; Marguerite R Kelher; Anirban Banerjee; Xiayuan Liang; Kevin J Land; Kirk C Hansen
Journal:  Transfusion       Date:  2011-08-31       Impact factor: 3.157

5.  Serum peptidome profiling in patients with gastric cancer.

Authors:  Juan Yang; Yong-Chun Song; Cheng-Xue Dang; Tu-Sheng Song; Zhi-Gang Liu; You-Min Guo; Zong-Fang Li; Chen Huang
Journal:  Clin Exp Med       Date:  2011-07-08       Impact factor: 3.984

Review 6.  Personalized protein corona on nanoparticles and its clinical implications.

Authors:  Claudia Corbo; Roberto Molinaro; Mateen Tabatabaei; Omid C Farokhzad; Morteza Mahmoudi
Journal:  Biomater Sci       Date:  2017-02-28       Impact factor: 6.843

Review 7.  Glycans and glycoproteins as specific biomarkers for cancer.

Authors:  Muchena J Kailemia; Dayoung Park; Carlito B Lebrilla
Journal:  Anal Bioanal Chem       Date:  2016-09-03       Impact factor: 4.142

8.  The Use of Principal Component Analysis in MALDI-TOF MS: a Powerful Tool for Establishing a Mini-optimized Proteomic Profile.

Authors:  Changli Shao; Yaping Tian; Zhennan Dong; Jing Gao; Yanhong Gao; Xingwang Jia; Guanghong Guo; Xinyu Wen; Chaoguang Jiang; Xueji Zhang
Journal:  Am J Biomed Sci       Date:  2012

Review 9.  Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears.

Authors:  M E de Noo; R A E M Tollenaar; A M Deelder; L H Bouwman
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

10.  Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer.

Authors:  Rajasree Menon; Qing Zhang; Yan Zhang; Damian Fermin; Nabeel Bardeesy; Ronald A DePinho; Chunxia Lu; Samir M Hanash; Gilbert S Omenn; David J States
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.